Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.
RF Industries (NASDAQ:RFIL) announced its fourth-quarter 2024 earnings, showcasing a notable turnaround with its first operating profit in several quarters, despite missing earnings per share (EPS) ...
DBS may declare a special dividend, according to analysts. Singapore’s big three banks are expected to report “seasonally ...